📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Licenced doses of approved COVID-19 vaccines may not be optimal: A review of the early-phase, dose-finding trials. (2023)

First Author: Dunn DT

Attributed to: Respiratory infections funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.vaccine.2023.06.037

PubMed Identifier: 37355453

Publication URI: http://europepmc.org/abstract/MED/37355453

Type: Journal Article/Review

Volume: 41

Parent Publication: Vaccine

Issue: 31

ISSN: 0264-410X